Leczenie systemowe przerzutow do mozgu u chorych na czerniaka
Author(s): Ida Cedrych, Marian Reinfuss, Marek Jasiowka, Jerzy Jakubowicz, Pawel Blecharz, Tomasz Walasek
Based on literature data we discussed systemic treatment of brain metastases in patients with melanoma. It has been shown that among cytotoxic drugs only fotemustine and temozolomide showed real but relatively low effect. Small profit yielded application trials of interleukin 2 and interferon alfa-2b, as well as adaptive therapy. The possibility of improving the outcome of melanoma patients with brain metastases was created by entering into clinical practice CTLA4 monoclonal antibodies and inhibitors of serine threonine kinases.
Share this article
Submitted PhD thesis in Biotechnology at GITAM University, Vizag.
The Past Head, General Administration of Pharmaceutical Care at Ministry of Health,
Saudi Arabia Critical Care/TPN
Clinical Pharmacist Ministry of Health,
Riyadh, Saudi Arabia.
Department of Radiation Oncology
Asahi University Hospital
Gifu city, Gifu, Japan
Maher Abdel Fattah Al-Shayeb
Department of Surgical Sciences, Ajman University, UAE
Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)
Citations : 61
- Euro Pub
- Google Scholar
- Medical Project Poland
- Cancer Index
- Gdansk University of Technology, Ministry Points 20